Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Summary of Reportable Segments (Detail)

v3.23.1
Segment Information - Summary of Reportable Segments (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Revenues $ 36,753 $ 42,790  
Gross profit 15,512 22,492  
Depreciation and amortization 6,454 8,406  
(Recoveries), write-downs and other charges, net 516 57  
Net (loss) income (18,595) (10,102)  
Purchase of property, plant and equipment 1,002 1,573  
Purchase of other intangible assets 5 61  
Assets 297,528   $ 303,467
Eastern Region      
Segment Reporting Information [Line Items]      
Revenues 22,011 24,785  
Gross profit 10,621 16,068  
Depreciation and amortization 4,472 5,258  
(Recoveries), write-downs and other charges, net (1) 69  
Net (loss) income (5,914) 7,328  
Purchase of property, plant and equipment 989 1,219  
Assets 225,060   226,458
Western Region      
Segment Reporting Information [Line Items]      
Revenues 14,565 17,716  
Gross profit 5,172 6,411  
Depreciation and amortization 1,853 3,013  
Net (loss) income 440 (913)  
Purchase of property, plant and equipment 10 351  
Assets 59,981   60,896
Other      
Segment Reporting Information [Line Items]      
Revenues [1] 177 289  
Gross profit (281) 13  
Depreciation and amortization 129 135  
(Recoveries), write-downs and other charges, net 517 (12)  
Net (loss) income (12,241) (16,517)  
Purchase of property, plant and equipment 3 3  
Purchase of other intangible assets 5 $ 61  
Assets $ 12,487   $ 16,113
[1] Revenues from segments below the quantitative thresholds are attributable to an operating segment of the Company that includes revenue from the sale of CBD products throughout the United States. This segment has never met any of the quantitative thresholds for determining reportable segments nor does it meet the qualitative criteria for aggregation with the Company’s reportable segments.